Peer-Reviewed Journal Details
Mandatory Fields
O'Connell, J.,Houston, A.,Bennett, M. W.,O'Sullivan, G. C.,Shanahan, F.
2001
March
Nat Mednat Med
Immune privilege or inflammation? Insights into the Fas ligand enigma
Validated
()
Optional Fields
7
33
271
4
Fas ligand (FasL) has become an enigmatic molecule: some evidence indicates that it contributes to immune privilege in tissues and tumors, whereas other data demonstrates that FasL can elicit inflammation. New findings may begin to reconcile the paradoxical effects of FasL.Fas ligand (FasL) has become an enigmatic molecule: some evidence indicates that it contributes to immune privilege in tissues and tumors, whereas other data demonstrates that FasL can elicit inflammation. New findings may begin to reconcile the paradoxical effects of FasL.
1078-8956 (Print) 1078-89
Grant Details